Business context and reporting period
The filing is Portman Ridge Finance Corporation’s Form 10-K for the fiscal year ended December 31, 2022, filed March 9, 2023. The request metadata names BCP Investment Corp, but the filing itself identifies Portman Ridge Finance Corporation (NASDAQ: PTMN); verify the intended issuer. Portman Ridge is an externally managed BDC and RIC focused primarily on middle-market loans, with additional joint-venture and CLO investments. This summary covers the full year and fourth quarter of 2022.
Financial performance and condition
- Investment income: $69.6 million for 2022, down from $80.1 million in 2021. Core investment income excluding merger-related purchase-discount amortization was $64.2 million, compared with $63.4 million.
- Net investment income: $28.9 million, or $3.00 per share, versus $42.0 million, or $4.92 per share, in 2021. Tax-basis distributable income was $29.6 million, or $3.07 per share.
- Net result: Net realized investment losses were $31.2 million and net unrealized depreciation was $17.9 million; net decrease in net assets from operations was $21.0 million, or $2.18 per share. In 2021, operations produced a $26.0 million increase.
- Fourth quarter: Portfolio interest and related income was $18.6 million; net investment income was $7.1 million, or $0.74 per share. Net assets declined $12.4 million from operations, or $1.28 per share.
- Portfolio and returns: Investments were $576.5 million at fair value, versus $547.6 million a year earlier. The debt portfolio’s weighted-average contractual interest rate rose to 11.1% from 8.1%; four debt investments were on non-accrual. The portfolio spanned 119 entities and 31 industries, excluding CLOs, joint ventures and asset manager affiliates. Senior secured loans were 73% of portfolio fair value; junior secured loans were 10%.
- Net assets and NAV: Net assets were $232.1 million, down from $280.1 million. NAV per share fell to $24.23 from $28.88. The stock closed at $23.00 at year-end, below NAV.
- Cash flow and liquidity: Operating cash flow was negative $33.1 million, compared with positive $61.1 million in 2021. Year-end cash and cash equivalents were $5.1 million; restricted cash was $28.0 million and held for borrowing-related interest and principal payments. Unfunded investment commitments totaled $35.0 million, including $8.0 million to a joint venture.
- Debt and coverage: Par borrowings totaled $378.2 million, with a weighted-average rate of 6.1%; the 1940 Act asset coverage ratio was 160%, above the 150% minimum. Debt included $178.2 million par of 2018-2 CLO secured notes, $108.0 million of 4.875% notes due 2026 and $92.0 million outstanding on the revolving facility. The facility was amended in 2022, extending its reinvestment and scheduled termination dates to April 2025 and April 2026, respectively.
- Distributions: The company declared $2.56 per share for 2022, including $0.67 for the fourth quarter. On March 9, 2023, the Board declared a $0.68-per-share distribution payable March 31, 2023.
Material changes versus the prior comparable period
- Investment income decreased 13% year over year, while core investment income was modestly higher. Merger-related purchase-discount amortization fell to $5.4 million from $16.6 million, contributing to the reported decline.
- Net investment income fell about 31%, and results shifted from a $26.0 million increase in net assets from operations in 2021 to a $21.0 million decrease in 2022. The 2022 result included materially higher realized losses and continued unrealized depreciation.
- Portfolio fair value increased about 5%, but NAV per share declined about 16%. Debt costs rose: interest and debt-issuance-cost expense increased to $17.7 million from $13.6 million, and the reported weighted-average debt rate rose from 3.2% to 6.1%.
- The debt portfolio’s weighted-average contractual rate rose to 11.1% from 8.1%, reflecting higher rates and floating-rate exposure. Approximately 90% of debt investments at par were floating rate.
- Year-end cash and restricted cash together fell to $33.1 million from $68.3 million. Unfunded commitments declined to $35.0 million from $47.9 million.
Outlook, risks, contingencies and unusual items
- Management provided no specific earnings or investment-return guidance. It intends to continue quarterly distributions as determined by the Board, subject to earnings, liquidity, RIC requirements, debt covenants and asset-coverage limits.
- The company was evaluating, at an early stage, a potential merger with one or more affiliated funds; any transaction could use an exchange ratio other than NAV-for-NAV. No outcome or timetable was specified.
- Key risks include leverage and limited headroom above the 150% asset-coverage minimum; rising funding costs and refinancing or covenant risk; borrower defaults and portfolio-company stress; illiquid and judgment-based valuations; floating-rate and benchmark-transition exposure; and potential limits on capital raising while shares trade below NAV.
- Most investments are illiquid and Level III. Level III investments totaled $471.2 million; the auditor identified their fair-value estimates as a critical audit matter because they require significant judgment and unobservable inputs.
- Four debt investments were on non-accrual. PIK income was $5.6 million, which is accrued income rather than necessarily cash received. CLO subordinated investments are leveraged and may defer or lose distributions.
- Two HCAP-related shareholder lawsuits remained at an early stage. The company said neither outcome nor reasonably possible loss could be estimated; insurance coverage may not cover all adverse damages.
- Management concluded disclosure controls and internal control over financial reporting were effective at year-end. The independent auditor did not provide an internal-control attestation, which the company said was not required.
Important facts for investors to verify
- Confirm the intended filing entity: the supplied metadata says BCP Investment Corp, while the 10-K is for Portman Ridge Finance Corporation (PTMN).
- Review the audited financial statements and portfolio schedules for the drivers of the $31.2 million realized loss, $17.9 million unrealized depreciation and four non-accrual loans.
- Assess cash available for operations separately from restricted cash, the $35.0 million of unfunded commitments and upcoming debt maturities or refinancing needs.
- Check asset coverage and facility/CLO covenants, especially given 160% coverage versus the 150% regulatory floor and the revolving facility’s 2025–2026 dates.
- Evaluate distribution sustainability against tax-basis distributable income, cash receipts (including PIK and CLO income), and the Board’s discretion.
- Track the HCAP litigation and any affiliated-fund merger proposal, including any exchange ratio and conflicts-of-interest safeguards.